Bayer is leveraging generative AI in collaboration with Amazon Web Services (AWS) to enhance drug discovery by predicting chemical reaction conditions more efficiently. In a six-week project, AWS developed a chatbot for scientists and created AI models that accurately predict reaction conditions, significantly reducing time and costs. This innovative approach aims to streamline the drug discovery process, ultimately accelerating the delivery of therapies to patients. Future advancements will build on these foundational achievements.